How are weight loss drugs affecting Greggs' sales?

Greggs' CEO stated that appetite-suppressing medications are having an impact, leading customers to seek smaller portions and healthier options.

What healthier options has Greggs introduced?

Greggs has launched products like egg pots and overnight oats with seeds and fruit, focusing on protein and fiber content.

What were Greggs' recent sales figures?

Greggs reported a 7.4% increase in total sales for the quarter ending December 27, 2025.

Home / Business and Economy / Greggs Boss: Weight Loss Drugs Impacting Bakery Sales

Greggs Boss: Weight Loss Drugs Impacting Bakery Sales

8 Jan

•

Summary

Greggs CEO notes appetite suppressants affect sales, driving demand for healthier options.
The bakery introduced smaller portions and protein-rich products to cater to new trends.
Greggs reported a 7.4% total sales jump in the last quarter despite market challenges.

Greggs Boss: Weight Loss Drugs Impacting Bakery Sales

Greggs' chief executive, Roisin Currie, has stated that appetite-suppressing medications are undoubtedly impacting the bakery chain's business. She noted a clear consumer shift towards smaller portions and an interest in nutritional information regarding protein and fiber content. This trend is prompting Greggs to adjust its offerings to meet these evolving customer preferences.

Currie clarified that while the rise of GLP-1 medications, known for suppressing appetite, is a factor, it aligns with a broader societal health trend. To capitalize on this, Greggs has introduced new healthier products, selling half a million egg pots since their autumn launch and recently adding an overnight oats option. Despite these shifts, hot snacks also remain popular, with 1.3 million hot food items sold weekly on average.